# Claude Code session transcript

*Session:* Validating Question 4 and reconciling the notebook with three re-runs — Claude Code on the web (remote environment), model Opus 5  
*Session ID:* `e6bd1eee-cef6-5bfa-9470-37961aa5985f`  
*Span:* 20 September 2026 15:26 to 22 September 2026 00:46 (Sydney time)  
*Converted on 22 September 2026 from the session record by `export_claude_session.py`. Every prompt and every reply is included verbatim and unedited. As the AI-use guidance anticipates, tool output and the model's internal reasoning are omitted, and each tool call is listed by name. Background-task notifications and automatic app messages are shown as quoted markers so the replies to them read in context.*

---

### Sunday 20 September 2026

## You  _15:26_

Okay I am going to start validating question 4, so looking at cell 113, it is checking whether these trials have all the features we could build on?

## Claude  _15:26_

I'll look at the notebook to find cell 113 and the Question 4 context.

<details><summary>tools run</summary>

- `Bash: List repo contents and git state`

</details>

<details><summary>tools run</summary>

- `Bash: Dump notebook cell index`

</details>

<details><summary>tools run</summary>

- `Bash: Print cell 112 markdown`

</details>

<details><summary>tools run</summary>

- `Bash: Print cell 113 source`

</details>

<details><summary>tools run</summary>

- `Bash: Print cell 113 outputs`

</details>

<details><summary>tools run</summary>

- `Bash: Print cell 114 markdown`

</details>

<details><summary>tools run</summary>

- `Bash: Print Q3a feature assembly cells`

</details>

<details><summary>tools run</summary>

- `Bash: Print Q3a trial/text feature cells`

</details>

<details><summary>tools run</summary>

- `Bash: Inspect database zip contents`

</details>

<details><summary>tools run</summary>

- `Bash: Check scratchpad and disk`

</details>

<details><summary>tools run</summary>

- `Bash: Unzip database and list tables`

</details>

<details><summary>tools run</summary>

- `Bash: Inspect Asclepius tables`

</details>

<details><summary>tools run</summary>

- `Bash: Locate python environments`

</details>

<details><summary>tools run</summary>

- `Bash: Show Asclepius table schemas`

</details>

<details><summary>tools run</summary>

- `Bash: Dump Asclepius readouts and scenario filing metadata`

</details>

<details><summary>tools run</summary>

- `Bash: Print cell 115 Q4a step 2`

</details>

<details><summary>tools run</summary>

- `Bash: Trace co_year, asc, mesh_area definitions`

</details>

<details><summary>tools run</summary>

- `Bash: Print asc construction lines in cell 75`

</details>

<details><summary>tools run</summary>

- `Bash: Find phase_bucket and match_confidence definitions`

</details>

<details><summary>tools run</summary>

- `Bash: Print mesh_area function`

</details>

<details><summary>tools run</summary>

- `Bash: Print cell 116 Q4a step 3`

</details>

<details><summary>tools run</summary>

- `Bash: Print Q2a feature matrix cells`

</details>

<details><summary>tools run</summary>

- `Bash: Search markdown for SPY/XBI mentions`

</details>

<details><summary>tools run</summary>

- `Bash: Check FDA feature nulls by application type`

</details>

<details><summary>tools run</summary>

- `Bash: Check FDA prior-approval value distribution`

</details>

<details><summary>tools run</summary>

- `Bash: Confirm FDA table cardinality`

</details>

I read cell 113 end-to-end, traced what it feeds, and checked its factual claims against the database. Answering your question first, then what I found.

## What cell 113 is actually doing

Close to your reading, but sharper. It isn't asking "do these trials have all the features" — it's asking **which of the 451 Q3 feature columns Asclepius can supply for a trial that hasn't reported yet**, and it sorts every column into four states rather than present/absent:

- `scenario` (2) — `tr_outcome`/`tr_outcome_group`, the thing being assumed, not missing data
- `available` (26) — derivable today
- `supplied` (404) — exists only because the IR team drafted a filing
- `absent` (19) — nothing produces it

It's load-bearing, not commentary: the three lists it emits (`AVAIL_COLS`, `TEXT_COLS`, `ABSENT`) are exactly what cell 116 refits the model on (`"available only [used for Q4]"`), so a misclassification here propagates straight into the headline estimates.

## What checks out

- Counts reconcile: 451 = 384 emb + 20 named text + 23 trial + 24 company; 67-row table = 451 − 384; absent 19 = 13 `cx_` + 6 `co_`.
- `ASCL` has genuinely 0 rows in `stock_prices` — confirmed directly, and the ticker is right (`asclepius_readouts.ticker = 'ASCL'`).
- The categorical levels Q4a step 2 writes in actually exist historically: `tr_phase` = "Phase 3"/"Phase 2" matches `phase_bucket`; `tr_match_conf = "high"` is a real level; `co_fda_app_type = "none"` is the `fillna("none")` level carrying 61% of training rows. No silent `handle_unknown="ignore"` drop.

## Findings, worst first

**1. `co_fda_prior_appr = 0.0` contradicts how the training data encodes the same situation.** In `event_fda_features`, a drug with no FDA record has `fda_application_type` NULL **and `fda_n_prior_approvals` NULL** — that's 1,512 of 2,482 rows (60.9%). Cell 86 passes that NULL straight through, so historically "investigational, no FDA record" means NaN → median-imputed → missingness indicator = 1. Cell 115 gives Asclepius a hard `0.0`, indicator = 0. But `0` is an *observed* value meaning something different: 397 rows have a matched application type with zero prior approvals. So the ASCL rows are encoded as "in the FDA database, first approval pending" rather than "no FDA record", which is the group its 1,512 analogues sit in. `co_fda_app_type="none"` already carries the correct signal; the fix is to leave `co_fda_prior_appr` NaN. This is in `AVAIL_COLS`, so it reaches the final estimates.

**2. The catch-all `return "available", "trial design, from asclepius_readouts"` is itself a quiet assumption** — which is what the cell's own header says it avoids ("so no column is quietly assumed to be present"). 19 trial columns hit that fallback, and at least five aren't from `asclepius_readouts` at all:
- `tr_biologic` / `tr_genetic` — that table has no `intervention_types` column; the values come from a hand-written dict at cell 75 (`{"ASC-101": "BIOLOGICAL", …}`).
- `tr_n_drugs_filing` / `tr_multi_drug` — set to 1.0/0.0 in cell 115 on the assumption "one asset per announcement". Defensible, but it's an assumption about a filing that doesn't exist, and 39% of training rows are multi-trial.
- `tr_has_registry = 1.0` — asserted; there's no NCT ID for these three.
- `tr_area` — `mesh_area(conditions, "")` on a free-text condition string, vs registry MeSH terms *plus ancestors* historically. It lands correctly for all three (Rare/Genetic, Cardio/Metabolic, Rare/Genetic), but "genuinely available, not approximated" in the markdown overstates it.

An explicit whitelist plus `assert` on anything unmatched would make the cell do what it claims.

**3. Cell 114 explains 15 of the 19 absent columns.** "That removes the entire `cx_` block at a stroke" is wrong — zero ASCL prices removes 9 of the 13 `cx_` columns. The other four (`cx_spy_ret_20`, `cx_spy_vol_20`, `cx_xbi_ret_20`, `cx_xbi_vol_20`) are market-wide, exist in the data today, and are absent for a completely different and more interesting reason your code already states: they'd have to be measured as at a 2027 filing date. Q3a's feature table (cell 87) documents them as a company-group feature, so a marker reconciling the two will come up four short. One sentence fixes it, and it's a better sentence than the one it replaces.

**4. Minor:** `tr_cluster` is classified `available` while its own reason string says "from design **and text**" — and `km.predict(X_asc)` does consume the draft-filing PCs. Check 6's invariance result defends it well, but the honest claim is "invariant to *which* draft, not computed without one", not fully independent of supplied material.

Note these are static + SQL checks — pandas isn't installed in this container, so I couldn't re-execute the notebook.

Want me to push fixes for 1–3 on `rz_working`? 1 and 3 are small and self-contained; 2 is a rewrite of `state_of` into an explicit map, which would also change the reason strings displayed in the 67-row table.

## You  _15:36_

yes fix all three

## Claude  _15:37_

Let me see the rest of cell 86 so I get the exact company column list.

<details><summary>tools run</summary>

- `Bash: Print tail of cell 86`

</details>

<details><summary>tools run</summary>

- `Bash: Find downstream users of f_state and the column lists`

</details>

<details><summary>tools run</summary>

- `Bash: Draft replacement source for cell 113`

</details>

<details><summary>tools run</summary>

- `Bash: Validate new classification map offline`

</details>

Classification map validated — reproduces the stored run exactly, so `AVAIL_COLS`/`TEXT_COLS`/`ABSENT` are unchanged. Now applying the three edits.

<details><summary>tools run</summary>

- `Bash: Draft replacement markdown for cell 114`

</details>

<details><summary>tools run</summary>

- `Bash: Apply the three fixes to the notebook`

</details>

<details><summary>tools run</summary>

- `Bash: Verify patched notebook parses and diff size`

</details>

<details><summary>tools run</summary>

- `Bash: Confirm only intended cells changed`

</details>

<details><summary>tools run</summary>

- `Bash: Try installing pandas to test the cell logic`

</details>

<details><summary>tools run</summary>

- `Bash: Execute patched cell 113 against stub context`

</details>

<details><summary>tools run</summary>

- `Bash: Negative test: assert fires on an unclassified column`

</details>

<details><summary>tools run</summary>

- `Bash: Verify cell 115 diagnostic still consumes f_state correctly`

</details>

<details><summary>tools run</summary>

- `Bash: Add explanatory print to cell 115 diagnostic`

</details>

<details><summary>tools run</summary>

- `Bash: Final verification of the notebook`

</details>

Now committing and pushing to `rz_working`.

<details><summary>tools run</summary>

- `Bash: Commit the three fixes`

</details>

<details><summary>tools run</summary>

- `Bash: Push to rz_working`

</details>

<details><summary>tools run</summary>

- `Bash: Fetch remote and inspect divergence`

</details>

My base was 14 commits stale — and one of those commits (`2472407 "Q4: ... fix the feature-audit counts"`) touches exactly the cells I edited. I'll redo the work against the current remote HEAD rather than push over it.

<details><summary>tools run</summary>

- `Bash: Reset to remote HEAD and relocate the Q4a cells`

</details>

<details><summary>tools run</summary>

- `Bash: Diff Q4a cells: stale base vs current HEAD`

</details>

Fix 3 is already done upstream (commit `2472407`). Fixes 1 and 2 are still open — cells 113 and 115 are byte-identical to my stale base. Let me confirm the current outputs and re-apply.

<details><summary>tools run</summary>

- `Bash: Check current stored output of cell 113`

</details>

<details><summary>tools run</summary>

- `Bash: Print current cell 114 paragraphs`

</details>

<details><summary>tools run</summary>

- `Bash: Re-apply fixes 1 and 2 to current HEAD`

</details>

<details><summary>tools run</summary>

- `Bash: Verify re-applied patch and re-run cell 113 harness`

</details>

<details><summary>tools run</summary>

- `Bash: Commit the re-applied fixes`

</details>

<details><summary>tools run</summary>

- `Bash: Push to rz_working`

</details>

Pushed to `rz_working` as `b904941`. Two of the three landed — the third was already fixed.

**Fix 3 was already done upstream.** My checkout was 14 commits stale, and one of them (`2472407`, "Q4: reconcile with the re-executed run, and fix the feature-audit counts") had already corrected "entire `cx_` block" → "every sponsor-specific price feature" and added the SPY/XBI sentence. I reset onto the real HEAD and re-derived the other two there rather than pushing over it. Cells 113 and 115 were byte-identical to my stale base, so findings 1 and 2 still stood.

**Fix 1 — `co_fda_prior_appr`** (cell 115): now `np.nan` instead of `0.0`, with the reasoning in a comment. The nine ASCL rows now carry the same encoding as the 1,512 historical rows with no FDA record — median fill plus a raised missingness indicator — rather than being presented as a matched drug awaiting its first approval.

**Fix 2 — the catch-all** (cell 113): `state_of()` is replaced by an explicit `mark()`-built map, asserted complete against `F.columns` in both directions. A feature added upstream now raises rather than silently becoming "available". Six columns carry a new `assumed` flag (`tr_biologic`, `tr_genetic`, `tr_has_registry`, `tr_match_conf`, `tr_n_drugs_filing`, `tr_multi_drug`) and are printed separately, and the absent list now prints in its three kinds rather than as one run-on line.

**Verification.** I installed pandas and executed the rewritten cell 113 against a stubbed context reconstructed from the Q3a definitions plus the real database. It reproduces the stored run exactly — 451 columns; 2 scenario / 26 available / 404 supplied / 19 absent; 28 carried (23 trial, 5 company). No column changes state, so `AVAIL_COLS`, `TEXT_COLS` and `ABSENT` are unchanged and the step 3 ablation (historical rows only) is untouched. I also ran a negative test confirming the assert fires on an unclassified column, and checked the cell 115 diagnostic that consumes `f_state` still works.

**Two things to know before you re-run:**

- I cleared the outputs on cells 113 and 115 rather than leave output contradicting the code. You'll need to re-run from cell 113 down.
- The cell 115 diagnostic will now read **available 26, populated 25**. That gap is fix 1, and it's deliberate — I added a two-line print saying so, and the markdown explains it, so a marker doesn't read it as a bug.

Cells 118/120/122 (the ASCL predictions) will shift slightly since one feature value changed for those nine rows; the figures quoted in the markdown around them may need a pass once you've re-run. Cell 116's ablation table won't move.

One judgement call worth flagging: I kept `co_fda_prior_appr` classified `available` rather than moving it to `absent`. Marking it absent would drop it from `AVAIL_COLS` entirely, removing it from training where the historical rows genuinely carry it. Keeping it in with a NaN for Asclepius is what matches the historical encoding. If you'd rather the state names read more strictly, that's a one-line change — but it would alter the re-scoped model.

## You  _15:46_

should i rerun the whole notebook

## Claude  _15:46_

Good question — let me check a few things that decide it rather than guess.

<details><summary>tools run</summary>

- `Bash: Check execution count ordering`

</details>

<details><summary>tools run</summary>

- `Bash: Print setup cell`

</details>

<details><summary>tools run</summary>

- `Bash: Audit seeding and randomness across the notebook`

</details>

<details><summary>tools run</summary>

- `Bash: Size the Q4a prediction cells`

</details>

Short answer: **not right now — but yes, once, before you submit.**

**Why not right now.** Nothing above cell 113 is touched by my edit. The only value that changed is one feature on nine rows of `F_asc`. If your kernel from the last run is still alive, run just `113 → 115 → 118 → 120 → 122 → 124`.

You can **skip 116** in that pass. It's the expensive cell — 5 configs × 2 splits × 3 seeds × 5 folds ≈ 150 random-forest fits — and it's fitted on historical `F` only, so its output is unchanged and its stored table stays valid. The variables it defines that the later cells need (`make_preprocessor_cols`, `SEEDS4`, `NO_MKTCAP`) are already in memory and unaffected, since `AVAIL_COLS` came out identical. What's left is cheap: 118 is one fit, 120 is five, 122 fits nothing.

That pass tells you the thing you actually need to know — how far the ASCL estimates moved — so you can fix the figures quoted in markdown 117/119/121/123. That reconciliation is the real work item, and it's the same either way.

**Why a full run eventually.** Your notebook is currently a clean single pass: execution counts 1→59 with no gaps. That's a submission-quality artifact and it shows in the HTML export. A partial re-run leaves you with 1…51, then 60, 61, 62 scattered through Q4, which reads as a notebook that doesn't run top-to-bottom — exactly the thing a marker checks for. One Restart & Run All at the end restores it.

**It should be safe.** Everything is seeded off `MEMBER_ID = 40100` — every `KMeans`, `PCA`, `TruncatedSVD`, `RandomForest`, `HistGradientBoosting`, the `GroupKFold`/`KFold` shuffles, and both `default_rng` calls carry an explicit seed. I found no unseeded randomness. So a full re-run on the same library versions reproduces Q1–Q3 exactly and moves only the nine Asclepius rows.

**The one caveat.** That holds only if the environment doesn't change. Your history has two "reconcile the prose with the re-executed run" commits, which is what a version shift costs you — if you do the final run somewhere else (a fresh Colab, an upgraded sklearn), expect numbers to move across all four questions and budget for that pass. If you're re-running in the same environment you've been using, you shouldn't see it.

If your kernel isn't still live, the question is moot — you'd be running everything from cell 2 regardless, so just do the full run and reconcile Q4 from it.

## You  _15:50_

okay i need to rerun the whole notebook before we continue to validate

## Claude  _15:50_

<details><summary>tools run</summary>

- `Bash: Check notebook kernel metadata`

</details>

<details><summary>tools run</summary>

- `Bash: Check gitignore, tree state, and local python stack`

</details>

Run it in your own venv, not here — and I'll hold off until you push.

**Why here would be the wrong place.** The notebook metadata says your last run was `dsa_assignment.venv (3.12.5)` — a local venv on your machine. This container has Python 3.11 as default, no sklearn, no torch, no sentence-transformers, and `.gitignore` excludes both `dsa_assignment.venv/` and `models/`, so neither your environment nor your cached encoder is here. Running it here would mean a different Python plus freshly-resolved latest versions of everything and a re-downloaded model — the maximum-drift case of exactly what I flagged last message. You'd likely get moved numbers across Q1–Q3 and be back doing the prose reconciliation you've already done twice. Your venv is the environment the current prose was reconciled against; keep it.

**While you're running, three things are worth eyeballing** — the re-run doubles as verification of the patch:

1. **Cell 113 must not raise.** It now ends in an assert. If it fires, a feature moved upstream and the message names the column.
2. **Cell 113's counts should be unchanged** from the stored run: 451 columns; 28 carried (23 trial, 5 company); 404 supplied; 19 absent. Plus two things that are new — six columns listed as assumptions (`tr_match_conf`, `tr_has_registry`, `tr_biologic`, `tr_genetic`, `tr_n_drugs_filing`, `tr_multi_drug`), and the absent list split 9 / 4 / 6. I verified all of this against a stubbed harness, but your run is the real check.
3. **Cell 115 should read `available 26, populated 25`.** That gap is fix 1 and it's deliberate; there's a print underneath saying so.

**Then the actual work:** cells 118/120/122 produce the Asclepius estimates, and those nine rows now carry a different `co_fda_prior_appr`, so the figures quoted in the Q4a (ii)–(v) markdown will need checking against the new output. Cell 116's ablation table should be identical — if it isn't, something other than my change moved, and that's worth knowing.

Push the re-executed notebook when it's done and I'll pick up validating Q4 from there. I'd carry on into Q4a (ii)–(v) — the estimates themselves, the range construction in cell 122, and whether the evidence-strength claims in (v) hold up — unless you'd rather I start somewhere else.

## You  _15:52_

yep i am doing it locally, in the meantime lets take a look at the code in cell 115, so it is making fake outcomes and outcome groups for each readout and extracting the data for it?

## Claude  _15:52_

Let me pull up the current cell 115 and the functions it borrows from earlier questions.

<details><summary>tools run</summary>

- `Bash: Print the feature-building body of cell 115`

</details>

<details><summary>tools run</summary>

- `Bash: Find result_sentences and classify_filing call sites`

</details>

<details><summary>tools run</summary>

- `Bash: Print clean_filing_text and classify_filing`

</details>

<details><summary>tools run</summary>

- `Bash: Measure cleaning effect on the scenario drafts`

</details>

Cleaning strips ~3,200 chars per draft, so it's not a no-op. The decisive question is whether the three *selected* sentences differ — let me check directly.

<details><summary>tools run</summary>

- `Bash: Compare selected sentences under both preprocessings`

</details>

<details><summary>tools run</summary>

- `Bash: Print result_sentences and its helpers`

</details>

<details><summary>tools run</summary>

- `Bash: Check drug_tokens behaviour and sentence selection divergence`

</details>

Let me verify the outcome → outcome_group convention the mapping relies on, since that's the core of what you're asking about.

<details><summary>tools run</summary>

- `Bash: Verify the outcome/outcome_group convention in the database`

</details>

Your reading is close, but "fake" undersells what's real and oversells what's invented. Three distinct things happen in that cell.

**The drafts are real rows, not fabrications.** `asclepius_scenario_filings` holds 9 actual rows — 3 readouts × 3 scenarios, ~1,350 words each, written by the IR team. The cell reads them; it doesn't make them up.

**What the cell does invent is the label.** `SCEN_TO_OUTCOME` maps each (readout, scenario) pair onto the dataset's six-category scheme. Positive and negative are mechanical. The three "mixed" drafts are the judgement, and ASC-204 is the one with teeth — headed "mixed" but the primary endpoint missed (HR 0.89, p = 0.071), read as mixed-*negative*.

**Then it extracts.** `asclepius_features()` builds a 9 × 451 frame in exactly `F`'s columns — trial block from `asclepius_readouts`, company block from the brief, text block from the drafts, everything else left NaN.

I verified the convention the mapping rests on. `event_study_enriched` does encode mixed-positive → Positive (188 rows) and mixed-negative → Negative (78), spelled exactly as `SIX_CATS` spells them. That part is sound.

## But the mean CARs undercut the prose

| outcome | n | mean CAR |
|---|---|---|
| positive | 1,756 | **+2.4%** |
| mixed-positive | 188 | **−6.3%** |
| mixed-negative | 78 | **−11.1%** |
| negative | 370 | **−18.8%** |

Cell 114 argues the mixed-positive/mixed-negative call "moves the row from one side of the distribution to the other" and would put ASC-204 "on the wrong side". That's true of the *group* label — Positive vs Negative — but not of the data. Both mixed categories average negative; they're on the same side. The real gap between the two readings is about 4.8 points of CAR, not the ~21 points separating positive from negative. The decision still matters and your call on ASC-204 still looks right to me, but the justification is currently reasoning from the label rather than from the distribution, and step 5's mixed-negative re-run of ASC-101 will show the smaller number. Worth reconciling the prose to it once you have the output.

## Two inconsistencies with how the historical rows were built

**1. Q2c and Q4a preprocess the same drafts differently** — and this one reaches your estimates. Cell 75 embeds `re.sub(r"\s+", " ", r.filing_text)`, raw text merely whitespace-collapsed. Cell 115 embeds `clean_filing_text(...)`, which is what Q1c used to build the historical space (`clean_lookup`). So Q4a follows the convention and Q2c doesn't. Cleaning strips ~3,200 chars per draft, and I checked the downstream effect: **the three selected sentences differ for 4 of the 9 drafts**. The cleaned version admits the `EXHIBIT 99.1 ...` headline as a sentence, because stripping the surrounding boilerplate brings that chunk inside `result_sentences`' 40–400 character window.

Those sentences become the text PCs that `km.predict` turns into `tr_cluster` — which is in `AVAIL_COLS`. Check 6 established the cluster is invariant across the three *drafts*; it never tested invariance to *preprocessing*. Whether the assignment actually moves, I can't tell without the fitted model and encoder, so it's an open question rather than a confirmed defect.

**2. `drug_tokens("ASC-101")` returns `[]`.** The helper drops tokens of 3 characters or fewer, so "asc" and "101" both vanish — same for ASC-204 and ASC-370. Sentence selection for all three readouts therefore runs with *no* drug-mention signal; the score collapses to result-language count alone, where a historical row like `TNX-102 SL cyclobenzaprine` contributes up to 5 points from the name. This hits Q2c and Q4a alike. `asclepius_readouts.acronym` would fix it cheaply — `drug_tokens("ASCEND-HAE")` yields `ascend`.

The same 3-character filter also means `A["tx_drug_named"] = 1.0` **contradicts its own definition**: cell 85's rule computes 0.0 for these drafts. It's in the text/supplied block, so it only touches the step-3 ablation, not the headline estimates — but it's a hand-set value disagreeing with the feature it's standing in for, the same class of thing as the catch-all we just fixed.

One more I checked and can dismiss: `classify_filing(scen_clean[a], scen_clean[a])` passes cleaned text where the historical call passes raw second. That argument only feeds `len(RE_PRIOR.findall(...))` → `tx_prior_refs`, and it's 0 under both preprocessings for all nine drafts. Inconsistent, zero effect here. Also minor: `tr_has_dmc`, `tr_n_drugs_filing` and `co_year` are hardcoded rather than read from `asclepius_readouts` / `expected_readout`. The values are all correct — I checked — but it's the same fragility we just removed from the audit.

**I haven't touched the notebook** — you're mid-run, and an edit now would waste it. Tell me when your run lands and I'll pick these up then; item 1 is the only one I'd call urgent, and it's a one-line change in cell 75 plus a re-check that the cluster holds.

## You  _16:00_

okay lets continue looking at the next code i will ask you to implement those fixes once we finish the run, in the meantime cell 116 its checking for the models with different amount of information and grouped up differently to see how the performance is?

## Claude  _16:00_

<details><summary>tools run</summary>

- `Bash: Print the tail of cell 116`

</details>

<details><summary>tools run</summary>

- `Bash: Print cell 117 markdown`

</details>

<details><summary>tools run</summary>

- `Bash: Check og_all, RF seed, SEEDS4`

</details>

<details><summary>tools run</summary>

- `Bash: Print cell 93 model builders`

</details>

<details><summary>tools run</summary>

- `Bash: Look for feature importance evidence in Q3b`

</details>

Your reading is right. Let me sharpen it and flag what I found.

**Two axes, doing different jobs.** Five feature sets × two fold groupings × three seeds × five folds = 150 forest fits. The feature sets are the ablation proper — what is the missing information worth. The grouping is about protocol realism: `accession` is the Q3 protocol, `ticker` is the one that matches Q4, because Asclepius appears in no training row and a company-grouped split is the only honest simulation of that. It also reports $R^2$ separately within positive and negative readouts, each against its own subset mean, which is the right way to do it.

The design has a genuinely good move in it: the `trial + company, no text` row exists so the drop from the full model doesn't conflate losing the text block with losing the company features. That's the kind of intermediate step most ablations skip.

## The main problem: the headline attribution isn't what the ablation tests

The gap from `trial + company, no text` to `available only` is exactly the 19 absent columns — and they are four different kinds of thing: 9 sponsor price features, 4 SPY/XBI market-regime features, 4 disclosure-history features, and 2 FDA fields. No config separates them.

The code comment says that gap "is the price history alone." That's flatly wrong — it's the whole 19. The markdown is better in one place (it enumerates "thirteen `cx_` features, the four disclosure-history features and the two FDA fields — costs 0.070") but then commits anyway: *"Almost all of it is the price history"*, and the "what that means in practice" paragraph pins the entire loss on `cx_idio_vol` and `cx_vol_120`.

That's untested, and the rival explanation is strong. `co_prior_abs_car` is the company's mean absolute prior CAR — literally "how big are this company's reactions usually" — which is a *more* direct estimate of magnitude than residual volatility is. Cell 86's own describe output shows it populated for 2,089 of 2,482 rows (84%), mean 0.143. There's no permutation importance anywhere in the notebook, so nothing currently distinguishes the two.

**This changes the Q4b recommendation, which is why it matters.** If the loss is the price series, the fix is "Asclepius needs to be listed and seasoned." If it's the disclosure history, the fix is "after one or two readouts the model gets materially better" — a much nearer-term and more actionable thing to tell the board, and it's the sort of claim Q4b's refresh plan should rest on.

Cheap to resolve: one more config, `AVAIL_COLS + the four co_prior_* columns`, isolates the disclosure history. That's 30 extra fits against the 150 already running.

## Three smaller things

**The "run-to-run standard deviation" is fold-draw variance only.** `SEEDS4` feeds `folds_for(split, seed=s)`, but the forest builder `_rf(leaf, mf)` pins `random_state=MEMBER_ID`, so the model's own randomness never varies. The prose leans on that 0.003 fairly hard ("a real loss, not a rounding error"). The conclusion survives — 0.070 against even several times 0.003 is still real — but the quantity is narrower than "run-to-run" implies. Cell 120 does vary the model seed, so the distinction is clearly known; it just isn't the one being quoted here.

**`RF` is defined twice and captured as a default argument.** Cell 89 defines it as a plain lambda; cell 94 rebinds it to the swept-and-selected forest. Cell 116's `def oof_cols(cols, folds, model_fn=RF)` binds whatever `RF` is *at definition time*. In a clean top-to-bottom run that's the Q3b-chosen forest, which is what you want. But re-executing cell 89 after cell 94 would silently swap the model underneath cell 116 with no visible sign. Good argument for the full run you're doing; worth a comment so it doesn't bite later.

**`max_features=0.3` is proportional.** Removing the text block doesn't just remove information, it also changes how many features each split considers — so the ablation isn't purely informational. Standard practice, but a caveat sentence would be honest.

One useful checksum for when your run lands: **cell 116's numbers should come back identical.** It fits on historical `F` only, and my `co_fda_prior_appr` change touches nothing but the nine Asclepius rows. If that table moves, something other than my edit did it, and that's worth chasing before anything else.

## You  _16:06_

i stopped the run, lets make all the fixes first before i run it

## Claude  _16:06_

Let me get the exact context before editing — cell 75's head, and how widespread the `drug_tokens` issue is historically.

<details><summary>tools run</summary>

- `Bash: Print head of cell 75`

</details>

<details><summary>tools run</summary>

- `Bash: Measure drug_tokens emptiness across historical rows`

</details>

That changes my earlier recommendation. Let me check the `drug_tokens` signature before deciding.

<details><summary>tools run</summary>

- `Bash: Inspect drug_tokens signature and call sites`

</details>

<details><summary>tools run</summary>

- `Bash: Check has_dmc storage type and expected_readout format`

</details>

Now I'll apply the fixes. Let me pull the exact strings I'm replacing.

<details><summary>tools run</summary>

- `Bash: Print exact blocks to patch in cell 115`

</details>

<details><summary>tools run</summary>

- `Bash: Patch cells 75 and 115`

</details>

Now cell 116 — the ablation config and the attribution.

<details><summary>tools run</summary>

- `Bash: Patch cell 116 ablation`

</details>

<details><summary>tools run</summary>

- `Bash: Patch markdown cells 114 and 117`

</details>

<details><summary>tools run</summary>

- `Bash: Verify patches and simulate new cell-115 expressions`

</details>

<details><summary>tools run</summary>

- `Bash: Verify cell 116 config construction offline`

</details>

<details><summary>tools run</summary>

- `Bash: Check for remote drift before committing`

</details>

<details><summary>tools run</summary>

- `Bash: Commit and push all fixes`

</details>

Pushed as `5893982`. Cells 75, 114, 115, 116 and 117 changed; outputs cleared on the three code cells.

**One of my earlier recommendations was wrong, and I reversed it.** I'd suggested feeding the trial acronym into `drug_tokens` to restore the drug-mention signal for `ASC-101`. Then I measured it: **420 of 2,615 historical rows (16%) hit the same empty-token path** — TNX-102, LYR-210, SD-101, exactly the short-hyphenated-code shape. Asclepius isn't anomalous, it's typical of that group. Adding the acronym would have made those nine rows behave *unlike* the training rows they most resemble. So I left the behaviour alone and documented it, and for the same reason `tx_drug_named` is now computed by the rule (which returns 0) rather than hard-coded to 1.0.

**What went in:**

*Cell 75 — the one that can move your numbers.* The drafts were embedded from raw whitespace-collapsed text while `pca_full` and the space it projects into were fitted on `clean_filing_text()` output. Now cleaned. `tr_cluster` is in `AVAIL_COLS`, so watch whether the assignment holds.

*Cell 115.* `tx_drug_named` by rule; `classify_filing(clean, raw)` matching the historical call; `tr_has_dmc` and `co_year` read from the table instead of hard-coded (values verified unchanged — 1.0 and 2027). The mixed-positive comment now carries the real means rather than the label logic.

*Cell 116.* Sixth config `available + disclosure history` isolating `co_prior_*`, with a printed decomposition; `sd over 3 seeds` → `sd over 3 fold draws`; `oof_cols` resolves `RF` at call time instead of freezing it as a default argument; the proportional-`max_features` caveat noted.

I verified offline against the real database: the gap between `trial + company` and `available only` is exactly the 19 absent columns, splitting 4 disclosure-history / 15 other; the new config is 32 columns; the `PRIOR_HIST` guard assert passes; and every new cell-115 expression produces the value I predicted.

**Two things need you after the run:**

1. **Cell 117 has a marked placeholder** — `[TO COMPLETE AFTER THE RUN: ...]` — for the disclosure-history split. I won't invent that number. It's flagged in the text, but don't ship without filling it. If the disclosure history turns out to be the larger share, the two paragraphs below it are written for the price-series reading and need reversing; the code prints which one wins so you don't have to eyeball it.

2. **Q4a (iii)'s five existing rows should come back identical** — they're fitted on historical data only. That's still your checksum. Cells 118/120/122 will move, both from the FDA fix and now possibly from the cluster change.

One open question I deliberately didn't touch: `drug_tokens` drops the parenthetical by default, which is a documented, deliberate choice for sentence *ranking*, but it's why `TNX-102 SL (cyclobenzaprine HCl sublingual tablets)` scores no drug signal despite having a perfectly searchable generic name in it. Fixing that would improve sentence selection for 16% of rows — and shift every number in Q1 through Q4, meaning a full prose reconciliation across all four questions. That's your call, not mine, and it's a bigger decision than anything above. Happy to scope it if you want to see what it'd involve.

## You  _16:12_

is it better not to drop the parenthesis

## Claude  _16:13_

Let me measure it rather than argue it.

<details><summary>tools run</summary>

- `Bash: Measure the parenthetical trade-off across the corpus`

</details>

Mixed picture — the existing docstring's precision argument is real. Let me test a third option.

<details><summary>tools run</summary>

- `Bash: Test a cascading fallback and measure its blast radius`

</details>

One more measurement — this is where it might actually bite.

<details><summary>tools run</summary>

- `Bash: Measure sentence collapse within multi-drug filings`

</details>

Measured it three ways. Short answer: **dropping it is right as a default and wrong as an absolute** — but the flag isn't the fix.

**Flipping `keep_parenthetical=True` globally is a bad trade.** It halves the empty-token rate (16.1% → 8.8%, 190 rows rescued) and the rescues are genuinely good — `ALO-02 (oxycodone/naltrexone ER)` gains `oxycodone`, `naltrexone`; `SOF/VEL` gains `sofosbuvir`, `velpatasvir`. But it also injects junk into rows that were already fine: `oral` (20 rows), `solution` (18), `vaccine` (17), `ophthalmic` (17), `sublingual` (16), `with` (14), `treating` (13), `therapy` (9). `with` and `treating` match nearly any sentence. The docstring's precision argument is correct, and I'd keep the default as it is.

**A cascade is strictly better than either.** Outer tokens when they exist; the parenthetical only when they don't; the bare code as a single literal when there's still nothing:

| | empty tokens | rows affected |
|---|---|---|
| current | 420 (16.1%) | — |
| `keep_parenthetical=True` | 230 (8.8%) | 2,615 (all) |
| cascade | **0** | 420 (16.1%) |

It touches *only* the rows that currently have nothing, so the 84% with good tokens are untouched and the precision cost is exactly zero. And tier 3 is strong: searching `vx-371` as one literal rather than splitting it into `vx`/`371` finds the drug in **224 of 230 filings (97%)**, with none of the substring risk that `asc` matching "ascending" would carry.

**One thing I expected to find and didn't.** I thought the real damage would be in multi-drug filings — that rows with no drug signal would collapse onto identical sentences. The collapse is real and worse than I'd guessed (261 of 435 multi-drug filings give two or more drugs the same three sentences, 344 duplicate rows), but the cascade only fixes 31 of those 344. The collapse is mostly caused by something else, so that argument doesn't support the change. I'm flagging it because it's the strongest case I could have made and it didn't survive checking.

**What it costs: 340 rows (13% of 2,615) get different selected sentences.** That propagates through the embeddings into Q1c's diagnostics, Q2a's clustering and everything downstream.

**My recommendation: do it now, or decide not to and document it.** Now is the only cheap moment — you've stopped the run, so the re-execution is free; doing it after means a third full reconciliation pass. The implementation is about five lines and I can test the token logic offline before you run. My guess is the reconciliation lands mostly in Q1c and Q2a rather than Q3/Q4, since Q3b already found the text block worth ~0.005 and indistinguishable from noise — but that's a guess I can't verify without your run, so treat it as the main risk.

If you'd rather not, the fallback is to write the 16% / 97% / 340-row numbers into Q1c as a measured limitation with the fix stated but not taken. That's honest and still shows the work — weaker than fixing it, but it costs you nothing and it's a defensible call this late.

Say the word and I'll implement the cascade; otherwise I'll write it up as a limitation.

## You  _16:16_

implement the cascade

## Claude  _16:17_

<details><summary>tools run</summary>

- `Bash: Implement the cascade in drug_tokens and its call sites`

</details>

Now let me verify the patched function against the real corpus.

<details><summary>tools run</summary>

- `Bash: Verify the patched cascade against the corpus`

</details>

<details><summary>tools run</summary>

- `Bash: Print cell 34 markdown`

</details>

<details><summary>tools run</summary>

- `Bash: Print tail of cell 34`

</details>

<details><summary>tools run</summary>

- `Bash: Patch markdown cells 34 and 114`

</details>

<details><summary>tools run</summary>

- `Bash: Build the reconciliation checklist`

</details>

<details><summary>tools run</summary>

- `Bash: Check what cell 18 computes with drug_tokens`

</details>

The notebook's own docstring in cell 18 already half-found this. Let me complete that note, then commit.

<details><summary>tools run</summary>

- `Bash: Update cell 18 docstring and check remote`

</details>

<details><summary>tools run</summary>

- `Bash: Commit and push the cascade`

</details>

Pushed as `4a7050c`. The cascade is in `drug_tokens` (cell 9), so every caller inherits it.

**Verified against the full corpus:** empty token lists go **420 → 0** in both modes, and **zero** names that already had tokens changed — I diffed the patched function against the pre-change one across all 2,615 names in both modes. Spot checks land where they should: `pembrolizumab` → unchanged, `TNX-102 SL (cyclobenzaprine...)` → tier 2, `AXS-05` → `['axs-05']` tier 3, `ASC-101` → `['asc-101']`.

**One thing turned out better than expected.** Cell 18's `drug_present()` docstring already records this bug being half-found — "Without it 199 records were reported absent on a search that had no tokens to run" — and fixed with `keep_parenthetical=True`. But the 230 code-only names still fell through to its `bool(toks) and ...` guard, which returns `False` for exactly the reason that docstring set out to prevent. The cascade makes that guard unreachable. I extended the docstring to say so rather than leaving it looking complete.

**And the hard-coded `tx_drug_named = 1.0` was right all along** — it just wasn't justifiable under the old rule. With the cascade the rule now returns 1.0 for all nine drafts on its own, so the value is derived instead of asserted.

Also routed Q3a's `tx_drug_named` through `drug_tokens` instead of its inline `>3` split, which was recording "not searched" as "not named" for every bare-code drug. Q1c (cell 34) documents the fix and — this is the part worth reading — qualifies the multi-drug claim sitting right next to it: **238 of 435 multi-drug filings still give two or more drugs the same three sentences.** The cascade only improved that from 261. I'd made that my strongest argument for the change earlier and it didn't survive measurement, so the notebook now says the `1/(trials in filing)` weighting is what actually contains the problem, not the sentence selection.

**Now the reconciliation, which is the real cost.** 340 rows (13%) get different sentences, so this propagates through the embeddings into essentially everything. Prioritised:

- **Certain and probably large:** cell 34 (the AUCs — 0.754 / 0.732 / 0.889 will all move), cell 35, and all of Q2 (cells 45, 47, 52, 54, 57, 61, 64, 67, 70, 73, 76, 77) since the clustering runs directly on the text PCs.
- **Certain, probably small:** Q3 (cells 95, 97, 101, 103, 107, 108) — Q3b already put the text block at ~0.005, so the R²s shouldn't move much. Cell 99 is the exception; it's the text ablation itself.
- **Also check:** cells 19 and 24 — `drug_in_text` feeds Q1a analysis 2 and the Q1b flagging, and 230 rows flip from a false "absent" to a real search result.
- **Q4:** 114, 117, 119, 121, 123, 125 — plus the marked `[TO COMPLETE AFTER THE RUN]` placeholder in 117 for the disclosure-history split.

Outputs are cleared on cells 9, 18, 75, 85, 113, 115 and 116. Everything else keeps its stored output until you run, so a full Restart & Run All is the only clean path from here.

## You  _17:03_

okay the whole notebook has been rerun, lets reconciliate the prose across the whole notebook

## Claude  _17:03_

<details><summary>tools run</summary>

- `Bash: Check whether the re-executed notebook has been pushed`

</details>

<details><summary>tools run</summary>

- `Bash: Pull the re-executed notebook and check run integrity`

</details>

Clean run: 59 cells, execution counts 1→59 monotonic, no errors. Let me dump the outputs so I can work against them.

<details><summary>tools run</summary>

- `Bash: Dump Q1a code outputs`

</details>

That's too verbose to work through manually. Let me triage automatically — find prose numbers that no longer appear anywhere in the new outputs.

<details><summary>tools run</summary>

- `Bash: Triage stale numbers across all markdown`

</details>

Only round-number prose surfaced, which makes me suspect the matcher is too permissive. Let me check the headline claims directly.

<details><summary>tools run</summary>

- `Bash: Check Q1c vectorisation diagnostic outputs`

</details>

The numbers have definitely moved — my triage was too permissive. Let me work through this properly, question by question.

<details><summary>tools run</summary>

- `Bash: Dump Q1b outputs`

</details>

<details><summary>tools run</summary>

- `Bash: Print MD 24`

</details>

The previous run's outputs are still in git for cells I didn't clear. Let me diff old vs new outputs directly — that makes this precise.

<details><summary>tools run</summary>

- `Bash: Diff old vs new outputs for Q1`

</details>

<details><summary>tools run</summary>

- `Bash: Find hardcoded 256 and get cell 18 output`

</details>

<details><summary>tools run</summary>

- `Bash: Extract summary lines from Q1a analysis-2 cells`

</details>

<details><summary>tools run</summary>

- `Bash: Print MD 19`

</details>

<details><summary>tools run</summary>

- `Bash: Check the NGNE example in the new output`

</details>

<details><summary>tools run</summary>

- `Bash: Get full flagging table and new tier-1 composition`

</details>

<details><summary>tools run</summary>

- `Bash: Get tier-1 outcomes and CARs`

</details>

Now I have what I need for Q1. Applying those edits.

<details><summary>tools run</summary>

- `Bash: Reconcile Q1 prose`

</details>

<details><summary>tools run</summary>

- `Bash: Diff Q1c and Q2a outputs`

</details>

Q2's clusters have re-numbered and resized — that's the biggest part of this. Let me checkpoint Q1 first.

<details><summary>tools run</summary>

- `Bash: Commit Q1 and dump the new cluster profile`

</details>

<details><summary>tools run</summary>

- `Bash: Print MD 54`

</details>

<details><summary>tools run</summary>

- `Bash: Get per-cluster silhouettes and new keywords`

</details>

<details><summary>tools run</summary>

- `Bash: Get Q2c check 2 and check 5 outputs`

</details>

<details><summary>tools run</summary>

- `Bash: Get negative shares and Asclepius cluster assignment`

</details>

Now I have the full Q2a picture. Rewriting the cluster table.

<details><summary>tools run</summary>

- `Bash: Rewrite MD 54 cluster table`

</details>

<details><summary>tools run</summary>

- `Bash: Print MD 45, 47, 52`

</details>

<details><summary>tools run</summary>

- `Bash: Get shuffled-label silhouette and w_text column headers`

</details>

<details><summary>tools run</summary>

- `Bash: Reconcile MD 45, 47, 52`

</details>

<details><summary>tools run</summary>

- `Bash: Print MD 57, 61 and the discriminator accuracy table`

</details>

<details><summary>tools run</summary>

- `Bash: Get the sampled trial titles per cluster`

</details>

<details><summary>tools run</summary>

- `Bash: Get cluster 7 sample`

</details>

Now rewriting the two Q2b/Q2c cells that name clusters.

<details><summary>tools run</summary>

- `Bash: Rewrite MD 57 keywords section`

</details>

<details><summary>tools run</summary>

- `Bash: Rewrite MD 61 and commit Q2a/Q2b`

</details>

<details><summary>tools run</summary>

- `Bash: Diff Q2c check outputs old vs new`

</details>

<details><summary>tools run</summary>

- `Bash: Print MD 64 and 67`

</details>

<details><summary>tools run</summary>

- `Bash: Get variance shares and outcome-conditional table`

</details>

<details><summary>tools run</summary>

- `Bash: Reconcile MD 64 and 67`

</details>

<details><summary>tools run</summary>

- `Bash: Print MD 70, 73, 76 and check-4 headers`

</details>

<details><summary>tools run</summary>

- `Bash: Get check-4 second table and Asclepius neighbours`

</details>

<details><summary>tools run</summary>

- `Bash: Draft MD 70 and 73`

</details>

<details><summary>tools run</summary>

- `Bash: Rewrite MD 70, 73, 76 and commit Q2c`

</details>

Q1 and Q2 done. Now Q3.

<details><summary>tools run</summary>

- `Bash: Diff Q3 outputs`

</details>

<details><summary>tools run</summary>

- `Bash: Get sweep selection output and MD 95`

</details>

<details><summary>tools run</summary>

- `Bash: Print MD 97 and 99`

</details>

<details><summary>tools run</summary>

- `Bash: Get full ablation output`

</details>

<details><summary>tools run</summary>

- `Bash: Get ridge negative-readout ablation figures`

</details>

<details><summary>tools run</summary>

- `Bash: Get the new Q4a(iii) ablation output`

</details>

The new ablation settles the open question — the split is essentially 50/50, not "almost all price history". Patching Q3 now.

<details><summary>tools run</summary>

- `Bash: Reconcile MD 95, 97, 99`

</details>

<details><summary>tools run</summary>

- `Bash: Print MD 91, 101, 103, 107`

</details>

<details><summary>tools run</summary>

- `Bash: Get decile and AUC output`

</details>

<details><summary>tools run</summary>

- `Bash: Get share_below_minus25 by decile`

</details>

<details><summary>tools run</summary>

- `Bash: Reconcile Q3 and commit`

</details>

Now Q4 — the largest remaining piece.

<details><summary>tools run</summary>

- `Bash: Get Q4a steps 1-2 outputs`

</details>

<details><summary>tools run</summary>

- `Bash: Get cell 115 tail and cell 118 output`

</details>

<details><summary>tools run</summary>

- `Bash: Get cell 118 tail and cell 120`

</details>

<details><summary>tools run</summary>

- `Bash: Print MD 119 and 121`

</details>

<details><summary>tools run</summary>

- `Bash: Reconcile MD 117, 119, 121`

</details>

<details><summary>tools run</summary>

- `Bash: Print MD 121 tail and MD 123`

</details>

<details><summary>tools run</summary>

- `Bash: Print MD 123 tail`

</details>

<details><summary>tools run</summary>

- `Bash: Reconcile MD 121 tail and MD 123`

</details>

<details><summary>tools run</summary>

- `Bash: Reconcile MD 34 and re-run triage`

</details>

<details><summary>tools run</summary>

- `Bash: Print Q1d and Q2d summaries`

</details>

<details><summary>tools run</summary>

- `Bash: Get Q1d and Q2d tails`

</details>

<details><summary>tools run</summary>

- `Bash: Reconcile Q1d/Q2d and check word counts`

</details>

<details><summary>tools run</summary>

- `Bash: Check summary word counts against limits`

</details>

My Q2d edit pushed it 22 words over the 500 limit. Trimming back.

<details><summary>tools run</summary>

- `Bash: Trim Q2d back under 500 words`

</details>

<details><summary>tools run</summary>

- `Bash: Get exact stability sentence text`

</details>

<details><summary>tools run</summary>

- `Bash: Trim Q2d under the limit`

</details>

<details><summary>tools run</summary>

- `Bash: Trim Q2d to under 500`

</details>

<details><summary>tools run</summary>

- `Bash: Finish Q2d trim and commit Q4 reconciliation`

</details>

<details><summary>tools run</summary>

- `Bash: Print Q3d summary`

</details>

<details><summary>tools run</summary>

- `Bash: Reconcile Q3d and print Q4b`

</details>

<details><summary>tools run</summary>

- `Bash: Trim Q3d and scan Q4b for affected claims`

</details>

<details><summary>tools run</summary>

- `Bash: Finish Q3d trim and reconcile Q4b`

</details>

<details><summary>tools run</summary>

- `Bash: Scan for remaining stale values`

</details>

<details><summary>tools run</summary>

- `Bash: Check contexts of remaining stale candidates`

</details>

<details><summary>tools run</summary>

- `Bash: Apply final fixes and verify integrity`

</details>

<details><summary>tools run</summary>

- `Bash: Get exact Q4b forward-chaining sentence`

</details>

<details><summary>tools run</summary>

- `Bash: Apply final fixes and verify`

</details>

<details><summary>tools run</summary>

- `Bash: Confirm the reconciliation is markdown-only plus cell 21`

</details>

<details><summary>tools run</summary>

- `Bash: Commit and push the reconciliation`

</details>

Reconciliation done and pushed — five commits, `ba35f49..bd2baad`. **30 markdown cells changed; one code cell.**

I worked it by diffing the old stored outputs (still in git for cells I hadn't cleared) against the new run, so every figure below is a before/after against real output rather than a re-reading of prose.

## Three places the conclusion changed, not just the number

**Q4a(iii) — the placeholder is resolved, and it overturns what the section said.** Of the 0.069 lost with the absent company columns: disclosure history **+0.035**, price series + market regime + FDA **+0.035**. A difference of 0.0001 against a fold-draw sd of 0.005. "Almost all of it is the price history" was wrong — it's a dead heat. That propagates into Q3b, Q4a(iv), Q3d and Q4b, where the refresh plan now has a new lead trigger: Asclepius's own first readout populates four features and recovers half the shortfall, while the other half waits on a traded price series and no refit can bring it forward.

**Q3a — the imputation comparison reversed.** Dropping rows without registry design now scores 0.209 against the imputed model's 0.203 on the same 2,094 rows. The 0.007 gap exceeds run-to-run noise, so the old "indistinguishable" reading no longer holds. Imputation is still right — it's what makes Q4 possible at all — but the paragraph now states the accuracy it costs instead of denying it.

**Q3b — two claims died.** The ungrouped split no longer reverses the forest/booster ranking, and ticker grouping now costs the forest *nothing measurable* (0.200 → 0.200) while costing the ridge 78% rather than 67%. Also: the sweep now selects booster depth 3, not 4.

## Q2 was the heavy lift

The cascade changed 13% of the text vectors, so the k=8 solution reorganised — cluster IDs permuted, the old open-label group split in two, and the ophthalmology cluster dissolved into the residual. I rewrote the eight-cluster table, keyword section, all six validation checks and Q2d against the new fit. Substantively: Ward now beats k-means on Davies-Bouldin so "worse on every measure" is gone; the phase-only lookup (0.062) now scores *above* the clustering (0.060), which strengthens the point; and cluster 0's respectable +0.044 accuracy gain has to be read against keywords containing `funding` and `99 ex` — a residual can be predictable from text without being a kind of trial.

Q4's substance survived: ASC-101 → cluster 6, ASC-204 → cluster 1, ASC-370 → cluster 3, still invariant to the draft, and ASC-204 still the only one clearing 30 negatives.

## Two things I'd want you to look at

**Cell 21 needs re-executing — it's the only unexecuted cell.** I removed a hard-coded "256 records" from the S2 signal description, which the run would otherwise print directly beside a count of 12. Everything else in this pass was markdown, so the notebook is otherwise still your clean 1→59 run. You'll want a final Restart & Run All before the HTML export regardless.

**My Q2d edit pushed it 22 words over the 500 limit.** I caught it on a word-count check and trimmed it back to exactly 500. All four summaries now sit at 496 / 500 / 499 / 299.

Three new findings worth a look, since they're the kind of thing a marker rewards: ASC-370's five nearest neighbours are now *all positive* reactions (+2.3% to +19.8%), so the retrieved set is silent on its downside; its negative scenario rests on **3** comparable records, the thinnest cell in the table; and ASC-101's retrieval screen now fails outright (22% clinically related against a 30% threshold), so its estimate falls back to a 754-record Phase 3 base rate. All three are stated plainly in Q4a(v) rather than left implicit.

---

### Monday 21 September 2026

## You  _01:29_

okay easy i have reran the whole thing now

## Claude  _01:29_

<details><summary>tools run</summary>

- `Bash: Pull and check run integrity`

</details>

<details><summary>tools run</summary>

- `Bash: Show execution counts`

</details>

Run is sequential with no gaps. Now the critical check — did anything other than cell 21 move?

<details><summary>tools run</summary>

- `Bash: Diff this run's outputs against the previous run`

</details>

No numbers moved — cell 21's label is fixed, and the rest is environment noise plus the notebook's own word counter. Let me read the completion check.

<details><summary>tools run</summary>

- `Bash: Read the completion check and verify cell 21`

</details>

<details><summary>tools run</summary>

- `Bash: Scan for outstanding submission placeholders`

</details>

The re-run is clean and — importantly — **nothing numerical moved.** I diffed every cell's output against the previous run: only cell 21 changed (the `S2_drug_absent` label now reads "the classified drug name appears nowhere in the filing" beside its count of 12, instead of the stale "256 records"). Everything else was a tqdm line and a warning that didn't re-fire. So the whole reconciliation still holds.

The notebook's own completion check passes: no `«FILL»` tokens outstanding, and all four word limits clear (Q1d 495, Q2d 494, Q3d 498, Q4c 299 by its counter).

**One thing to fix before you submit: the execution counts run 60–118, not 1–59.** You ran All without restarting the kernel, so the counter continued from the previous session. They're strictly sequential with no gaps, so the notebook genuinely executed top to bottom — but two reasons to do one final **Restart & Run All**:

1. A marker reading 60–118 can't tell at a glance that it's a clean single pass.
2. Without a restart, any variable defined in the earlier session that the current run doesn't redefine would persist invisibly. Low risk given it ran in order, but a restart is what proves it — and the `RF` rebinding between Q3a step 6 and Q3b step 2 is exactly the shape of thing that hides in a warm kernel.

Since nothing moved this time, that final run should reproduce identically. No further prose work should come out of it.

**Still outstanding for submission** — none of these are mine to write:

- **Cell 0**: `Member ID: [INSERT]` and `Date: [INSERT]`
- **Cell 133**: `**My video:** [INSERT YOUTUBE URL HERE]` — the brief requires the YouTube URL as a hyperlink at the bottom
- **Cells 36, 78, 109, 130**: the four AI-use sections are marked `TO COMPLETE BEFORE SUBMISSION`. Q4's (cell 127) is already written; Q1, Q2, Q3 and Q5 still carry the placeholder. These have to be your own truthful account, so I've left them alone — but you have a fairly complete record of this session's contribution in `ai_logs/` to draw on.

Want me to look at anything else while the run is fresh? The two places I'd still poke are Q4c (300 words, and it's the only section I haven't read closely this pass) and whether Q4b's new first-readout trigger reads well against the rest of that plan.

## You  _01:32_

so going back to cell 115, it runs the simulated outcomes and outcomes groups before they are fed into the model right

## Claude  _01:32_

<details><summary>tools run</summary>

- `Bash: Check the scenario-varying-features check in cell 120`

</details>

Yes on the ordering — but "simulated" is doing more work in that sentence than the code does.

**Nothing is generated.** `SCEN_TO_OUTCOME` is a hand-written nine-entry lookup mapping each (readout, scenario) pair to one of the six documented categories. The *scenarios* were simulated — by the IR team, who wrote three draft filings per readout, and those are real rows in `asclepius_scenario_filings`. What cell 115 does is **read** each draft and assign it a label. That reading is the only judgement in the cell, and ASC-204's is the consequential one: its "mixed" draft missed its primary endpoint, so it's labelled mixed-*negative* rather than taking the draft's own heading at face value.

**The ordering is right.** Cell 115 builds the 9 × 451 frame and touches no model. Cell 116 refits on historical data only. The model meets `F_asc` for the first time in cell 118, where `fit_avail` is fitted on the full historical `F` and then predicts the nine rows.

**The consequence is the part worth knowing.** Within the columns the Q4 model actually uses — `AVAIL_COLS`, with the text block set aside — the three scenarios of one readout are *the same row apart from those two columns*. Cell 120 checks this rather than assuming it, and this run printed exactly:

```
Features that differ between the three scenarios of one readout: ['tr_outcome', 'tr_outcome_group']
```

So the whole scenario separation — 16 to 27 points between the negative and positive estimates — flows through two categorical one-hot blocks. Design, cluster, therapeutic area, market cap are identical across all three. The model isn't reading the drafts at all in this configuration; it's being told "assume the label is X" and returning a conditional mean for that label given the trial's design. Which is exactly what the board asked — *what happens under each result* — but it's worth being clear that no part of the answer comes from the drafts themselves.

One small thing I noticed while checking: **those two columns are one degree of freedom, not two.** `tr_outcome_group` is a deterministic function of `tr_outcome` — positive and mixed-positive both map to Positive, negative and mixed-negative to Negative, and every composite label maps to "unknown". I verified against `event_study_enriched` that the mapping is many-to-one with no exceptions, and every `tr_outcome` level clears the encoder's `min_frequency=15` threshold, so nothing gets collapsed in a way that would make the coarser column carry information of its own. It's harmless in a forest and the audit is right to call both "scenario" — but when Q4a(i) says two columns are the assumption being varied, it's really one assumption expressed twice.

## You  _18:46_

okay so in cell 116, it checks for all the different models such which tests different combinations of information?

## Claude  _18:47_

<details><summary>tools run</summary>

- `Bash: Re-read cell 116's configs and fit loop`

</details>

One correction to the framing, and then something in the table worth a look.

<details><summary>tools run</summary>

- `Bash: Compute accession vs ticker gap per feature set`

</details>

<details><summary>tools run</summary>

- `Bash: Extract the R2 column block cleanly`

</details>

Not quite — and the distinction matters for what the cell can claim.

**Cell 116 holds the model fixed and varies the information.** It's one model throughout: the random forest as selected by the Q3b sweep (leaf=8, `max_features=0.3`, `random_state` pinned). What varies is six feature sets × two fold groupings × three fold draws × five folds = 180 fits of the same estimator.

The cell that tests different *models* is Q3b step 1 — three families (ridge, gradient boosting, random forest) across a hyperparameter sweep. Cell 116 deliberately doesn't do that: if you varied the model and the feature set together, you couldn't attribute a gap to either. Q3b picks the model; Q4a(iii) then asks what that model loses when you take information away.

The six sets, and what each is there to isolate:

| feature set | n cols | what it answers |
|---|---|---|
| all three groups | 451 | the Q3 reference |
| trial + company, no text | 47 | text removed, company intact |
| available only **[used for Q4]** | 28 | what Asclepius can actually supply |
| available + draft text | 432 | sizes the circularity being declined |
| available + disclosure history | 32 | splits the absent block in two |
| available, market cap removed | 26 | is market cap doing real work? |

And the two groupings answer a different question again — `accession` is the Q3 protocol, `ticker` is the one that matches Q4, because Asclepius appears in no training row.

## Something in the table I hadn't noticed

Look at what each feature set loses when you move from accession to ticker grouping:

| feature set | accession | ticker | change |
|---|---|---|---|
| all three groups | 0.1979 | 0.1973 | −0.001 |
| **trial + company, no text** | 0.2092 | 0.1922 | **−0.017** |
| available only | 0.1255 | 0.1230 | −0.003 |
| available + draft text | 0.1774 | 0.1751 | −0.002 |
| **available + disclosure history** | 0.1747 | 0.1576 | **−0.017** |
| available, market cap removed | 0.0966 | 0.1014 | +0.005 |

The two configs that lose ~0.017 are **exactly the two containing the disclosure-history block**. Everything else moves by essentially nothing. That's not a coincidence — `co_prior_mean_car` and `co_prior_abs_car` are built from the same company's earlier events, so under accession grouping the model can see other events from that company in training and those columns pay off. Under ticker grouping it cannot.

Two things follow. First, it's corroboration that those four columns are doing genuinely company-level work, arrived at from a direction the ablation wasn't designed to test. Second — and this is the reassuring part — **the write-up already quotes the right number.** The +0.035 for disclosure history in Q4a(iii) is measured on the ticker folds (0.1576 − 0.1230), not the accession folds, where it would have looked like +0.049. So the 50/50 split I reported is the honest Q4-relevant version, not the flattering one.

It's a nice observation and it's not in the notebook — the comment explains why the sixth row exists but not that the fold-design sensitivity independently confirms what it found. Want me to add two or three sentences to Q4a(iii)? It's markdown-only, so it wouldn't cost you another run.

## You  _18:50_

yes add it to Q4a(iii)

## Claude  _18:50_

<details><summary>tools run</summary>

- `Bash: Locate the insertion point in MD 117`

</details>

<details><summary>tools run</summary>

- `Bash: Add the fold-sensitivity passage to Q4a(iii)`

</details>

<details><summary>tools run</summary>

- `Bash: Verify markdown-only change and push`

</details>

Added and pushed as `af7cdf0`. One cell changed (117, markdown), so your run stays intact — no re-execution needed.

Two paragraphs went in after the "dead heat" finding:

**The corroboration.** Five of the six feature sets move by almost nothing between accession- and ticker-grouped folds (0.001 to 0.003), while exactly two lose ~0.017 — `trial + company` and `available + disclosure history`. Those are precisely the two containing the disclosure-history block, and nothing else distinguishes them. The mechanism is stated: `co_prior_mean_car` and `co_prior_abs_car` are built from the same company's earlier events, so accession grouping lets the model see other events from that company in training and ticker grouping doesn't. A block whose value depends on whether the company is in the training set is doing company-level work — which is what the sixth row was added to claim, now confirmed from a direction the ablation wasn't designed to test.

**Which number belongs where.** The disclosure history is worth +0.049 on accession folds and +0.035 on ticker folds. The section already quoted the smaller one, correctly — but only because I took it from the ticker block; the reason was never stated. It now is: Asclepius appears in no training row, so ticker grouping is the only protocol that reproduces its situation, and quoting the accession figure would overstate what one or two reported readouts recover by nearly half again.

That's a useful thing to have on the page for its own sake — it's the kind of "I checked whether my own number was the flattering one" move that's hard to claim credibly without the working shown.

## You  _19:00_

okay lets move on to cell 118

## Claude  _19:00_

<details><summary>tools run</summary>

- `Bash: Read cell 118 source`

</details>

<details><summary>tools run</summary>

- `Bash: Read the rest of cell 118`

</details>

<details><summary>tools run</summary>

- `Bash: Check whether Q4a(iv) discusses the non-monotonic ordering`

</details>

Before answering on 118 — I've spotted stale numbers in Q4a(iv) that my reconciliation pass missed. Let me check the full tail.

<details><summary>tools run</summary>

- `Bash: Read the sensitivity paragraph in Q4a(iv)`

</details>

<details><summary>tools run</summary>

- `Bash: Fix stale Q4a(iv) figures and check the mixed-positive count`

</details>

Cell 118 is where the estimates are actually produced. Four stages: fit the re-scoped model on all 2,482 historical rows and predict the nine cells; build the band from out-of-fold residuals within the matching outcome group; choose a comparable set per readout through a three-tier cascade; then the table, the monotonicity check and the chart.

**First, a correction to my own work.** My reconciliation pass missed three stale figures in Q4a(iv) — the seed-sd range end (0.68 → 0.72), the separation ratios (29/38/52 → 37/38/32), and the whole ASC-101 sensitivity sentence (8.3 pp from −6.5% to −14.8%, "nine times" → **7.8 pp from −7.9% to −15.6%, about seventeen times** the 0.47 pp seed variation). My triage script passed them because those values appear elsewhere in the notebook. Fixed, not yet pushed.

## What I'd question in the cell

**1. The document-cluster screen cannot fire in this fit, and not narrowly.** `is_doc` requires announcement share < 0.4 × 0.35 = **0.14** *and* flag rate > 1.2 × 0.52 = **0.62**. Observed announcement shares run 0.241–0.387 — the lowest is 69% of the median, nowhere near 40% — and flag rates run 0.444–0.586, the highest being 1.13× the median. Both conditions fail for every cluster, and neither is close. Reporting "none" is honest, but Q4a(ii) currently reads as though a live test came back negative. Saying how far it was from firing would be stronger.

**2. The retrieval uses only the mixed draft's text, and one readout depends on it.** `sim_to[rid] = cosine_similarity(X_asc[i], X)` takes `i` as the *mixed* scenario row, and `X_asc` includes the text PCs — which differ between the three drafts. Q2c check 6 established the **cluster** is invariant to scenario; nobody tested whether the **neighbour ranking** is.

It only bites for one asset, but it bites hard:

| readout | comparable set chosen by | exposed? |
|---|---|---|
| ASC-204 | cluster 1, same area (246 ≥ 40) | no |
| ASC-101 | Phase 3 base rate (both tests failed) | no |
| **ASC-370** | **50 nearest neighbours** | **yes** |

So ASC-370's comparable distribution — in all three of its scenarios — is derived from the IR team's mixed draft. That's the same circularity the model deliberately avoids by dropping the text block, arriving through the comparable set instead. And ASC-370 is the asset Q4a(v) says retrieval *rescues*, so it's the one place the claim rests on it.

**3. The band is borrowed, not estimated for Asclepius.** The residual quantiles come from the historical pool within outcome group. Asclepius sits at the 79th percentile of market cap with neither a price history nor a disclosure record, so its true residual spread is plausibly wider than the pool's. Q4a(iv) argues the bands are "correctly wide" and "conservative at the extremes" — that's a reasoned argument, but this construction doesn't measure it, and the prose doesn't flag that the width is inherited.

**4. Smaller things.** `res_q` only holds `Positive` and `Negative` keys — safe because all nine scenarios map to those two, but a KeyError if a draft were ever read as inconclusive. `MIN_IN_CLUSTER = 40` and `MIN_RELATED = 0.30` are asserted rather than derived from anything in Q2a, the same class of quiet assumption cell 113 now flags. And `comparable median` is displayed for n = 3 (ASC-370 negative) while p10/p90 are correctly suppressed below n = 8 — the median gets no such guard.

Item 2 is the one I'd actually act on. Testing it is cheap — recompute `sim_to` from the positive and negative rows and see whether ASC-370's top 50 move — but it's a code change, so it costs you a run. Want me to write that check, or note it as a limitation in Q4a(v) and leave the run alone?

> **Automatic message from the app** _19:02_ — "Stop hook feedback: [~/.claude/stop-hook-git-check.sh]: There are uncommitted changes in the repository. Please commit and push these changes to the remote branch."

## Claude  _19:02_

<details><summary>tools run</summary>

- `Bash: Check uncommitted changes`

</details>

<details><summary>tools run</summary>

- `Bash: Commit and push the Q4a(iv) corrections`

</details>

Pushed as `b6475f0` — one markdown cell, no re-execution needed.

That was the Q4a(iv) fix from my previous message: the seed-sd range end (0.68 → 0.72), the separation ratios (29/38/52 → 37/38/32), and the ASC-101 label sensitivity (8.3 pp from −6.5%/−14.8% at "nine times" → **7.8 pp from −7.9% to −15.6%, about seventeen times** the 0.47 pp seed variation). The argument there is unchanged and slightly stronger — the label reading dominates model noise by a wider margin than the stale text claimed.

Worth noting why my triage missed them: the script only flagged prose numbers that appear *nowhere* in the notebook's outputs, and `0.68`, `29`, `52`, `8.3` and `0.94` all exist elsewhere in other tables. It's a weak check for exactly this failure mode — a right-looking number attached to the wrong quantity. I found these by reading the section rather than by scanning, which is the only thing that catches them.

Back to where we were on cell 118 — the open question is item 2 from my last message: ASC-370's comparable set is built from the mixed draft's text embedding, and Q2c only ever established that the *cluster* is scenario-invariant, not the *neighbour ranking*. Your call on whether to test it in code (costs a run) or record it as a limitation in Q4a(v) (markdown only).

## You  _19:13_

note it as a limitation in Q4a(v)

## Claude  _19:13_

<details><summary>tools run</summary>

- `Bash: Locate the ASC-370 cautions in Q4a(v)`

</details>

<details><summary>tools run</summary>

- `Bash: Add the retrieval limitation to Q4a(v)`

</details>

<details><summary>tools run</summary>

- `Bash: Commit and push the Q4a(v) limitation`

</details>

Pushed as `8bf7102` — cell 123 only, markdown, no re-execution needed.

The ASC-370 paragraph now carries four cautions instead of three. The new one makes three moves:

**States the mechanism precisely.** The similarity is computed from the mixed scenario row alone, and that vector includes the Q1c text components, which differ between the three drafts because they're three different documents. It draws the distinction explicitly: Q2c check 6 tested that the *cluster* is invariant to the draft, not that the *neighbour ranking* is — a cluster boundary can sit far enough away to be insensitive to the text while the ordering of the fifty closest trials is not.

**Bounds the damage.** ASC-204 draws from cluster + therapeutic area, ASC-101 from the Phase 3 base rate — neither touches the draft text. Only ASC-370 uses the retrieved set, and because that set is built once, all three of its scenarios inherit it. So the exposure is one asset, and it's the one whose case rests on retrieval working, which is what makes it worth saying rather than burying.

**Doesn't overclaim.** It says plainly that I haven't measured it, names the test (recompute the similarity from the positive and negative rows, compare the top fifty), and says what each outcome would mean — retire the caution, or report ASC-370's comparable columns as a range across the three drafts. In the meantime it marks those figures indicative and prefers the cluster-level and base-rate numbers where they disagree.

That last part is the bit that earns its place: an untested limitation stated as untested, with the experiment specified, reads as better work than one quietly resolved by assertion.

Where next — cells 120 and 122, or something else?

## You  _19:18_

so cell 120 checks where the uncertainties come from

## Claude  _19:19_

<details><summary>tools run</summary>

- `Bash: Read cell 120 source`

</details>

Right — it's the decomposition cell. Three sources on the same nine cells, plus a fourth appended at the end.

| source | what it is | how it's measured |
|---|---|---|
| outcome uncertainty | not knowing the result | max − min of the three scenario points |
| model limitation | not knowing how far, given the result | mean width of the 80% band |
| run-to-run noise | the forest's own randomness | sd across 5 refits, `random_state` varied |
| label reading | how a human classifies "mixed" | ASC-101 re-scored as mixed-negative |

Two details it gets right that are easy to get wrong: the alternative-label run uses `fit_avail.predict` on a modified row rather than refitting (same model, changed input — correct), and it draws the alternative band from `res_q["Negative"]` rather than reusing the positive one, because changing the reading changes the outcome group.

## Three things worth raising

**1. The most consequential effect of the label reading isn't reported.** The cell prints "the reading is worth 7.8 pp on the point estimate" — but look at what happens to the band:

```
read as mixed-positive   point  -7.9%   80% band -25.8% to  +9.8%   (35.6 pp)
read as mixed-negative   point -15.6%   80% band -58.7% to +10.4%   (69.1 pp)
```

The point moves 7.8 pp. **The band nearly doubles** — 35.6 to 69.1 pp — because the row crosses into the Negative residual pool, which is twice as wide. For a CFO sizing a downside that's the bigger consequence, and both the code's print and Q4a(iv) quote only the point shift. The p10 goes from −25.8% to −58.7%; that's the number a treasury function would actually plan against.

**2. The decomposition doesn't add up, and the table invites reading it as though it does.** For ASC-101: outcome 26.8 + model band 46.7 = 73.5, against a full range of 87.5. The 14 pp gap is real, not rounding — `total` is `max(p90) − min(p10)`, which is the separation *plus the upper half of the positive band plus the lower half of the negative band*, while the "model band" column is the *mean* of three bands of unequal width. The gap varies by asset (14.0, 2.8, 8.7 pp). Q4a(iv) says "the rest — the majority — is the width of the band around a *single* scenario", which isn't quite what the residual is. The qualitative claim survives intact; the arithmetic as presented doesn't reconcile.

**3. The brief's test is passed, but it's a low bar by construction.** `seed_sd` varies only the forest's `random_state`, on a model fitted to all 2,482 rows every time — no fold variation, no resampling of the training corpus. With 400 trees that noise is always going to be a fraction of a point, so a ratio of 32–38 against a 16–27 pp separation is close to guaranteed for any non-degenerate model. Q4a(iv) already narrows the claim in the right direction ("what separates them is the model's conditional response to the assumed outcome label"), but it doesn't say the test is easy to pass. Noting that would be more honest than letting "a ratio of 37" carry weight it hasn't earned — especially since the fold-draw sd from cell 116 (0.005 on R²) is a different and larger quantity that this cell doesn't touch.

Item 1 is the one I'd act on — it's a finding rather than a caveat, and it strengthens the section: the mixed-label reading is not just worth 7.8 points of central estimate, it's the difference between a −26% downside and a −59% one. Want that added to Q4a(iv)?

## You  _19:20_

yes add it to Q4a(iv)

## Claude  _19:21_

<details><summary>tools run</summary>

- `Bash: Add the band-doubling finding to Q4a(iv)`

</details>

<details><summary>tools run</summary>

- `Bash: Commit and push the Q4a(iv) addition`

</details>

Pushed as `7973e3c` — cell 121 only, markdown.

The sensitivity paragraph now carries a small table alongside the point estimate:

| ASC-101, mixed draft | point | 80% band | width |
|---|---|---|---|
| read as mixed-positive | −7.9% | −25.8% to +9.8% | 35.6 pp |
| read as mixed-negative | −15.6% | −58.7% to +10.4% | **69.1 pp** |

With the mechanism stated — re-reading the label moves the row from the Positive residual pool to the Negative one, and those pools aren't the same width — and the line that matters for the reader: the 10th percentile falls from −25.8% to **−58.7%**, a 33-point move on a single classification judgement. Someone who takes the thromboembolic safety signal to dominate isn't nudging the central estimate by eight points; they're describing a materially different downside.

That also strengthens the existing claim rather than replacing it. "How a human classifies the result is a larger source of uncertainty than which model is fitted" was already true on the point estimate at 17× the seed variation; on the band it's not close.

**Two things from cell 120 I raised and didn't act on**, still open if you want them:

- **The decomposition doesn't reconcile.** Outcome 26.8 + model band 46.7 = 73.5 against a full range of 87.5, because `total` is `max(p90) − min(p10)` while the band column is a *mean* of three unequal bands. The gap is 14.0 / 2.8 / 8.7 pp across the three assets. Q4a(iv)'s "the rest is the width of the band around a single scenario" isn't quite what the residual is. Fixable in a sentence.
- **The brief's separation test is a low bar.** `seed_sd` varies only the forest's `random_state` on a model fitted to all rows, so the noise is always a fraction of a point and a ratio of 32–38 is near-guaranteed. Worth saying the test is necessary rather than impressive.

Otherwise the remaining Q4 cell is 122.

## You  _19:31_

okay lets move on to cell 122

## Claude  _19:31_

<details><summary>tools run</summary>

- `Bash: Read cell 122 source`

</details>

<details><summary>tools run</summary>

- `Bash: Read cell 122 output`

</details>

<details><summary>tools run</summary>

- `Bash: Check my 754 claim in Q4a(v)`

</details>

<details><summary>tools run</summary>

- `Bash: Fix my own base-rate error and push`

</details>

<details><summary>tools run</summary>

- `Bash: Fetch and inspect the new remote commit`

</details>

<details><summary>tools run</summary>

- `Bash: See what the user's commit changed`

</details>

<details><summary>tools run</summary>

- `Bash: Diff their edit to cell 121`

</details>

They pushed an edit to cell 121 (trimmed a sentence from my addition) while I was editing cell 123. Different cells, so I'll rebase mine onto theirs rather than merge JSON.

<details><summary>tools run</summary>

- `Bash: Re-apply my edit on top of their commit`

</details>

<details><summary>tools run</summary>

- `Bash: Commit and push with retry`

</details>

Pushed as `059aa2c`. Your cell 121 trim is preserved — I rebased onto it rather than merging, since we'd touched different cells.

**First, an error of mine that cell 122 exposed.** I'd written in Q4a(v) that ASC-101 "falls back to the broad Phase 3 base rate of **754** records." 754 is only the positive-outcome subset. The base-rate set is **1,050**, of which **237** are negative — and it's the negative one the downside scenario rests on. Now stated properly, with the 237 called out, because that's the number behind ASC-101's −21.3%.

## What cell 122 is

Two jobs. The evidence table — comparables, same-area and same-phase counts, outcome-category coverage, median sponsor, flag rate per readout — plus an indication-level reality check (7 / 31 / 3 trials in the whole clustered set mention each indication). Then a deliberate anti-drift block: **"FIGURES QUOTED IN THE Q4a WRITE-UP"**, printing every number the prose cites so the two can't diverge. That's a good device and I haven't seen it elsewhere in the notebook.

## Three problems, all in that anti-drift block

**1. It prints an equation that doesn't hold.**

```
ASC-101  full span 87 pp = outcome 27 pp (31% of width) + model band 47 pp
```

27 + 47 = 74, not 87. Same for the other two (24 + 58 = 82 vs 85; 16 + 47 = 63 vs 72). The `=` and `+` are literally false — `full span` is `max(p90) − min(p10)` while `model band` is the *mean* of three bands of unequal width, so they don't compose. This is the code version of the non-additivity I flagged in cell 120, and it's worse here because it's printed as arithmetic.

**2. It still says "price history costs −0.0693".** That's the whole 19-column block, which the sixth ablation row showed splits 50/50 with the disclosure history. I corrected this in the cell 116 comment, in Q3b, Q4a(iii) and Q4b — but the block whose entire purpose is stopping prose and run drifting apart is itself printing the superseded claim.

**3. It says "run-to-run sd 0.0046"**, the label I changed to *fold-draw* sd in cell 116 because the model seed is pinned across those three runs.

All three are print-label changes — no computation is affected, so a re-run would reproduce every number identically. And you need a **Restart & Run All** before submission anyway to get the execution counts back to 1–59 from the current 60–118. So fixing these costs nothing if bundled into that final run.

Want me to make those three edits now so they're carried by the final run?

## You  _19:33_

yes make those three edits

## Claude  _19:34_

<details><summary>tools run</summary>

- `Bash: Apply the three fixes to cell 122`

</details>

Let me verify the new identity holds and tighten the comment — ASC-370's non-monotonicity makes it subtler than I first wrote.

<details><summary>tools run</summary>

- `Bash: Verify the decomposition identity per readout`

</details>

<details><summary>tools run</summary>

- `Bash: Tighten the comment and match the prose`

</details>

<details><summary>tools run</summary>

- `Bash: Commit and push the cell 122 fixes`

</details>

Pushed as `1c3cd1f` — cells 121 (markdown) and 122 (code, outputs cleared).

**The equation fix.** Replaced the false `outcome + model band = full span` with an exact split: outcome separation plus a band contribution taken as the residual, with mean band width printed alongside as a description rather than a term. I verified the identity against the stored numbers before writing it:

```
ASC-101  87.5 = 26.8 (31%) + 60.7 (69%)
ASC-204  84.7 = 24.0 (28%) + 60.7 (72%)
ASC-370  71.8 = 16.4 (23%) + 55.4 (77%)
```

Those shares match the table in Q4a(iv) exactly, which is a good sign the two were always describing the same thing — only the printed arithmetic was wrong.

One subtlety I got wrong on the first pass and corrected: the residual has to be a *residual*, not "the positive band's upper half plus the negative band's lower half", because the extremes need not be the same scenarios. **ASC-370's point extremes are the mixed and positive cells while its band extremes are negative and positive** — a direct consequence of its non-monotonic ordering. The comment now says so, which also ties the two findings together.

**The attribution fix.** The block now names "the 19 absent company columns" and prints the split (`disclosure history +0.035, price series/regime/FDA +0.035`) that the prose quotes — so the anti-drift device actually carries the figure it's meant to protect.

**The label fix.** `run-to-run sd` → `fold-draw sd (model seed fixed)`.

I also matched Q4a(iv)'s prose, which had the same loose phrasing ("the rest is the width of the band around a single scenario"). It now gives the 69–77% share and explains why mean band width isn't a term in the sum.

Cell 122 is the only unexecuted cell. Nothing computational changed — only printed labels — so your final Restart & Run All will pick it up and every other number will reproduce.

That's Q4a done end to end: 113, 115, 116, 118, 120, 122. What's left in Q4 is 124 (the completion check) and the written answers 125 and 126, which we've touched but not read closely.

## You  _19:37_

can you double check about some of the features we dont have for ascelpius as it seems to be a listed company with share price based on the brief

## Claude  _19:37_

That's a serious challenge to a claim running through the whole of Q4. Let me read the brief.

<details><summary>tools run</summary>

- `Bash: Check PDF and install reader`

</details>

<details><summary>tools run</summary>

- `Bash: Extract brief text`

</details>

<details><summary>tools run</summary>

- `Read: DSA_2026_S2_Assignment_Final.pdf`

</details>

<details><summary>tools run</summary>

- `Bash: Extract PDF text manually`

</details>

<details><summary>tools run</summary>

- `Bash: Find PDF streams containing Asclepius`

</details>

No stream has it as plain text — subsetted fonts. Let me check what the notebook itself quotes from the brief, and what the database implies.

<details><summary>tools run</summary>

- `Bash: Search repo for brief details about Asclepius`

</details>

<details><summary>tools run</summary>

- `Bash: Find the brief's Asclepius description in logs/methodology`

</details>

<details><summary>tools run</summary>

- `Bash: Find the brief's company background in the AI logs`

</details>

<details><summary>tools run</summary>

- `Bash: Read the Q4 intro for the company description`

</details>

<details><summary>tools run</summary>

- `Bash: Check for listed companies absent from stock_prices`

</details>

Every historical company with a market cap has price data, so there's no precedent for "listed but missing". Let me find every place the notebook draws the wrong inference.

<details><summary>tools run</summary>

- `Bash: Find every claim that Asclepius has no price series`

</details>

You're right, and it's a real error — one I made worse. Here's what I can and can't verify.

**What I couldn't do:** read the PDF directly. Its fonts are subsetted with custom encodings, `pdftotext`/`pypdf`/`pdfminer` aren't installable in this container (the `cryptography` wheel panics), and no decompressed stream contains "Asclepius" as plain text.

**What the evidence says anyway:**

- `asclepius_readouts` gives ASCL a **`market_cap` of $6.0bn** and a **ticker**. A market capitalisation is shares × share price — it only exists for a company with traded equity.
- The notebook's own Q4a(v), written before I touched it, quotes the brief: Asclepius has **"$800m of CDMO revenue and a marketed respiratory portfolio behind the pipeline."** That's a commercial-stage company, not a pre-IPO biotech.
- Every one of the 317 historical companies with a market cap has price data in `stock_prices`. So a market cap in this dataset has always meant a listed company — ASCL is the only exception, and it's the fictional one.

So the correct reading is: **ASCL is listed; its price history simply isn't in this dataset.** "Zero rows in `stock_prices`" is true. "ASCL has no price series" is not.

## What that breaks

Nine places draw the wrong inference. Two are code:

| cell | claim |
|---|---|
| 113 | reason string `"...; ASCL has none"`, and the printed label |
| 116 | comment: *"Asclepius has to list and season before the model improves"* |
| 99 | *"an earlier draft got it wrong by assuming Asclepius has a price history"* |
| 117 | *"a matter of listing and then seasoning"*; *"missing because ASCL has no price series"* |
| 121 | *"half of it needs a price history for Asclepius"* |
| **125 (Q4b)** | *"waits on ASCL having enough traded history… not something a refit can bring forward"* |
| 127 | *"ASCL has no price history at all"* |

**Cell 125 is the damaging one, and it's mine.** I wrote that half the shortfall can only be recovered by waiting for ASCL to list and season. If ASCL is already listed, those nine `cx_` features are a **data-acquisition task** — pull its price history from the same source the other 320 tickers came from — doable before any readout, and it recovers ~0.035 of the 0.069 immediately. That inverts the Q4b recommendation from "wait years" to "fix this before the next refit," which is both more useful and more correct.

Two things are already correctly qualified and don't need touching: Q3d says "in this dataset" and Q4c says "not in the data".

**One question before I rewrite.** Does the brief say anything about *when* Asclepius listed? If it's a recent IPO, a short price history genuinely limits the 120-day estimation window and "seasoning" partly survives — the fix would then be "obtain what exists, and note the window may be short". If it's an established listing, the fix is unambiguous: get the data. Which does the brief imply?

## You  _19:42_

so what we know is it is listed but we dont have the price history due to a fictious company and that is also not in the data set right

## Claude  _19:42_

Right — and it's worth separating the two reasons, because they belong in different registers. Let me first confirm there's genuinely no ASCL price data anywhere.

<details><summary>tools run</summary>

- `Bash: Scan every table for any ASCL data`

</details>

Confirmed — and your framing is right. I scanned every table: `ASCL` appears **only** in `asclepius_readouts` and `asclepius_scenario_filings`. Zero rows in `stock_prices`, zero in `event_study_enriched`. The other hits are incidental substring matches inside free text.

There's one distinction worth drawing out, because it decides how the notebook should word this — there are **two different reasons** the data is missing, and they belong in different registers:

**In-world** (the scenario the board lives in): Asclepius is a listed company with a $6bn market cap, $800m of CDMO revenue and marketed products. Its price history *exists*. This dataset doesn't carry it. Obtaining it is a sourcing task.

**Out-of-world** (why it's actually absent): the Asclepius tables are authored fiction. `methodology.md` classifies them "Authored-fictional" and says they "describe no real trial, filing or market activity" — the authors never generated a price series, because there's no company to generate one for.

The notebook is written as advice to a CFO, so the prose should use the in-world framing. But the safest wording is the one true in **both** registers: *"the dataset supplies no price series for ASCL"* — factual, and it makes no claim about the company's corporate status. Then the deployment recommendation follows from the in-world fact that it's listed.

That's what's currently wrong. The notebook says "ASCL has none" and reasons from it to "must list and season", which is a claim about the *company* rather than about the *data*, and it's false.

**The fix, in two parts:**

1. **Nine wording changes** across cells 99, 113, 116, 117, 121, 125, 127 — replace "ASCL has none" / "has no price series" with "the dataset supplies no price series for ASCL". Two are code (113's reason string and print label, 116's comment), the rest markdown.

2. **Q4b's recommendation inverts, and this is the part that matters.** Instead of "half the shortfall waits on listing and seasoning, which a refit cannot bring forward", it becomes: *obtain ASCL's price history from the same market-data source as the other 320 tickers — a data-acquisition step that can be completed before the first readout and recovers roughly 0.035 of the 0.069 immediately.* The disclosure-history half still waits on the first real readout. So both halves become near-term and actionable, and the two have different owners — one is a data request, one is time.

That's a better answer than the one currently in there, and the current one would likely cost marks on Q4b.

Shall I make all nine? Cells 113 and 116 are code, so they'd join cell 122 in needing the final Restart & Run All — no computation changes, labels only.

## You  _19:43_

yes make all nine

## Claude  _19:44_

<details><summary>tools run</summary>

- `Bash: Get exact text for each site`

</details>

<details><summary>tools run</summary>

- `Bash: Apply all nine corrections`

</details>

<details><summary>tools run</summary>

- `Bash: Verify no wrong inferences remain`

</details>

<details><summary>tools run</summary>

- `Bash: Commit and push the nine corrections`

</details>

Pushed as `57e0004`. Seven cells: 99, 113, 116, 117, 121, 125, 127. A regex sweep for the wrong inference now returns zero remaining sites.

**The wording is now register-neutral.** Everything says *"the dataset supplies no price series for ASCL"*, which holds whether the reader takes the in-world view (a listed company whose data we don't hold) or the provenance view (an authored table for which none was generated). Nowhere does it now claim the company lacks a price series.

**The substantive change is Q4b**, and it's a better answer than what was there:

> Asclepius is a listed company with a $6.0bn market capitalisation; what is missing is its price series *in this dataset*, not its trading history. Obtaining ASCL's daily closes and volumes from the same provider the other 320 tickers came from restores the nine `cx_` features… It requires no readout and no refit cycle, only a data request, and it should be raised before the next scheduled refit rather than after the first disclosure.

So the two halves of the shortfall now have different owners: **one is a purchase order, the other is time.** Only the disclosure history genuinely waits, because it needs Asclepius to have reported. I also added the caveat that the estimation window needs 130 trading days of prior history, so the sourcing request is specified properly rather than left as "get the prices".

Cells 113 and 116 join 122 as unexecuted — three cells, all label and comment changes, no computation touched. Your final Restart & Run All picks all three up and every number reproduces.

Two things worth saying plainly about this one. First, **it was my error in Q4b** — I wrote the listing-and-seasoning line two days ago and built the refresh plan's headline trigger on it. Second, it's the kind of mistake the rest of the validation wouldn't have caught: every number was right, the arithmetic reconciled, the triage passed. What was wrong was the inference from a true fact, and only reading the brief against the data surfaces that. Good catch.

The one thing I still can't confirm is whether the brief says anything about *when* Asclepius listed. If it's a recent IPO, the 130-day window caveat becomes the main point rather than a footnote — the data request would come back short. Worth a glance at the brief while you're in it.

## You  _19:46_

But we are 100% sure their trading data doesnt exist in our database>

## Claude  _19:46_

Fair challenge — let me verify it properly rather than repeat myself. Three gaps in what I checked before.

<details><summary>tools run</summary>

- `Bash: Check the extra tickers and the incidental ASCL text hits`

</details>

<details><summary>tools run</summary>

- `Bash: Check for any other data source with ASCL prices`

</details>

<details><summary>tools run</summary>

- `Bash: Read data dictionary entries for stock_prices and Asclepius`

</details>

Yes — that part is certain. Five independent confirmations, and one of them is new:

**1. The data dictionary defines `stock_prices` as excluding it by design.** Its own description of the ticker column:

> *"Stock ticker. Covers the event-linked company tickers and, in addition, the three index ETFs used"*

Asclepius has no events, so it's out of scope by construction — not an omission.

**2. The dictionary says so explicitly about the Asclepius rows:**

> *"FICTIONAL: describes the Asclepius scenario trials, which are invented for Question 4 and are not part of the historical event study. **Do not append these rows to it.**"*

**3. The ticker arithmetic closes exactly.** 320 tickers in `stock_prices` = 317 event-linked companies + `SPY`, `XBI`, `IBB`. No residual.

**4. Every `%ASCL%` hit outside the two authored tables is a false positive** — I read them: "Juxta**scl**eral" in eligibility criteria, "**Ascl**etis" (a real Chinese pharma partner named in filings), and "VA**SCL**IR™" (a product name). None refers to Asclepius.

**5. There's no other data file.** The repo is the database, the dictionary, four PDFs, the notebooks and the AI logs. The dictionary certifies 12 tables / 227 columns / 509,477 rows, all documented — no price table for Asclepius exists anywhere.

## But separate the two claims, because they don't have the same certainty

| claim | confidence | rests on |
|---|---|---|
| ASCL's trading data is not in this database | **certain** | the five checks above |
| Asclepius is a listed company | **high, not certain** | the brief, which I can't read |

The listing status comes from: it has a ticker, it has a **market capitalisation** ($6.0bn — a quantity that only exists for traded equity), the brief describes CDMO revenue and a marketed portfolio, and you've read it and say it mentions a share price. That's strong. But it's inference plus your reading, not something the database asserts.

**Why that split matters for what I pushed.** The wording I used everywhere — *"the dataset supplies no price series for ASCL"* — is true under either reading, so the nine corrections are safe regardless. The **Q4b recommendation is the part that depends on the listing status**: "obtain ASCL's daily closes from the same provider" only makes sense if there's a listed security to obtain them for. If the brief turned out to describe a private company, that recommendation would revert to something closer to the original.

So: the fix is robust, one paragraph of it is conditional on the brief. Given the market cap and the marketed portfolio, I'd be surprised if it weren't listed — but you're the one who can see the brief, so that's yours to close.

## You  _19:51_

for asc-370 i read the prose in cell 123, is it possible to change the method and test it rather than write it as a limitation

## Claude  _19:52_

Yes — and it's the better answer. Let me restructure cell 118 so retrieval uses all three drafts symmetrically, and prints the stability statistic.

<details><summary>tools run</summary>

- `Bash: Get the exact sim_to block to replace`

</details>

<details><summary>tools run</summary>

- `Bash: Make retrieval symmetric across drafts and add the stability test`

</details>

<details><summary>tools run</summary>

- `Bash: Get the limitation paragraphs to replace`

</details>

<details><summary>tools run</summary>

- `Bash: Rewrite Q4a(v) around the method fix`

</details>

<details><summary>tools run</summary>

- `Bash: Commit and push the retrieval fix`

</details>

Pushed as `c023974` — cell 118 (code) and 123 (markdown).

**The method change.** The retrieval key is now the **mean of the three scenario rows** instead of the mixed one, so no single draft can decide the comparable set. I moved the `MIN_IN_CLUSTER` / `N_NEIGHBOURS` / `MIN_RELATED` constants above the similarity loop so the neighbour count is available where it's needed.

**The test.** Symmetry alone isn't enough — averaging three unstable answers still gives an unstable one. So the cell now prints, per readout:

| column | what it tells you |
|---|---|
| shared by all three drafts | how many of the top 50 survive every draft |
| mean pairwise overlap | typical agreement between any two |
| union over drafts | how far the candidate pool spreads |
| averaged set kept from the mixed draft | how much the old method would have given you |

That last column is the direct answer to the original question: if it's near 50, the old single-draft key was fine and the concern was theoretical; if it's much lower, the previous ASC-370 comparable figures were partly an artefact of which draft got picked.

**Q4a(v) is rewritten around the fix** rather than carrying a limitation — the fourth caution now explains what was wrong, what changed, and points at the printed diagnostic, with no invented numbers.

**One thing I should flag that I only noticed while writing this.** ASC-370 is the only readout whose comparable set *comes from* retrieval — but the **screen that routes all three** uses the same similarity. `rel_share` decides whether ASC-101 falls back to the base rate (it was 22% against a 30% threshold, so it failed by 8 points). If the averaged key moves that above 30%, ASC-101 switches from a 1,050-row Phase 3 base rate to a 50-neighbour retrieved set — a much bigger change than anything on ASC-370. So after the run, **check the printed basis line for all three**, not just ASC-370's numbers. It's in the commit message too.

Four cells now await the final run: 113, 116, 118, 122. Three are label-only; 118 is the one whose results can actually move.

## You  _19:56_

so now for asc370 it is also tested?

## Claude  _19:56_

<details><summary>tools run</summary>

- `Bash: Confirm cell 118 has not been run`

</details>

No — not yet. **The test is written; it hasn't run.** Cell 118 has `execution_count: None` and zero outputs, so no result exists for ASC-370 or anything else.

What's true right now:

- **The method is changed.** Retrieval keys on the mean of the three scenario rows, so the circularity is removed by construction. That part doesn't need a run to be true — it's a property of the code.
- **The measurement is instrumented but unmeasured.** The four diagnostic columns will be populated when you Run All.
- **The prose asserts no result.** Q4a(v) describes what was wrong, what changed, and points at the printed table. It deliberately doesn't claim an outcome, so nothing there is currently false.

So the honest status is: the instrument is built, the reading hasn't been taken.

**When you run it, the column to look at is `averaged set kept from the mixed draft`:**

| result | what it means | what to do |
|---|---|---|
| near 50 | the old single-draft key was fine; the concern was theoretical | add one sentence saying the test came back clean |
| 35–45 | material but not fatal | say so; ASC-370's comparable figures are indicative |
| well under 35 | the old figures were substantially an artefact of which draft was picked | Q4a(v) needs a follow-up sentence, and the ASC-370 comparable columns in cells 118/122 should be read as a range |

And the thing I flagged last message still stands as the bigger risk: **check the printed basis line for all three readouts**, not just ASC-370's numbers. ASC-101 failed the retrieval screen by 8 points (22% against a 30% threshold) under the old key. If the averaged key pushes it over 30%, ASC-101 switches from a 1,050-row base rate to a 50-neighbour set — which would change its point estimates, its bands and three paragraphs of Q4a(v). That's a larger consequence than anything the ASC-370 test can produce.

Four cells are queued for the run: 113, 116, 122 are label-only, 118 is the one that can move results.

## You  _19:57_

okay let me rerun the whole notebook again

## Claude  _19:57_

Good. One thing worth doing this time: **Restart & Run All**, not just Run All — last run continued the counter from 59, so the notebook came back numbered 60–118. A restart resets it to 1–59 and also proves no stale kernel state is propping anything up.

Four cells are queued. Three are cosmetic (113 and 116 comment/label text, 122's corrected print block). **118 is the one that can move results.**

When it lands I'll check, in this order:

1. **The basis line for all three readouts** — this is the bigger risk, not ASC-370. ASC-101 failed the retrieval screen by 8 points under the old key (22% vs the 30% threshold). If the averaged key pushes it over, ASC-101 switches from a 1,050-row base rate to a 50-neighbour set, which moves its estimates, its bands and three paragraphs of Q4a(v).
2. **The new stability table**, particularly `averaged set kept from the mixed draft` — that's the actual answer to the ASC-370 question.
3. **Whether ASC-370's comparable columns moved** in cells 118 and 122, and whether Q4a(v) needs its follow-up sentence.
4. **A full old-vs-new output diff** as before, to catch anything that shifted that shouldn't have — the three label-only cells should produce identical numbers.

Ping me when it's pushed.

---

### Tuesday 22 September 2026

## You  _00:40_

okay i have rerun it now and pushed it

## Claude  _00:40_

<details><summary>tools run</summary>

- `Bash: Pull and check run integrity`

</details>

Clean run — 1–59, sequential, no errors. Now the checks, in the order that matters.

<details><summary>tools run</summary>

- `Bash: Read the new retrieval stability and basis output`

</details>

<details><summary>tools run</summary>

- `Bash: Diff this run against the previous full run`

</details>

The test came back — and it inverts what I predicted. Let me check what prose needs updating.

<details><summary>tools run</summary>

- `Bash: Find prose affected by the retrieval change`

</details>

<details><summary>tools run</summary>

- `Bash: Write the test result into Q4a(v)`

</details>

<details><summary>tools run</summary>

- `Bash: Commit and push the test result`

</details>

Clean run: **1–59, sequential, no errors, nothing unexecuted.** Result written into Q4a(v) and pushed as `c307c84`.

## The test answered — and it inverts what I predicted

| | shared by all 3 drafts | mean pairwise | union | averaged kept from mixed |
|---|---|---|---|---|
| ASC-101 | 35 | 40.3 | 64 | 47 |
| ASC-204 | 23 | 30.0 | 83 | 38 |
| **ASC-370** | **43** | **45.7** | **56** | **46** |

**ASC-370 — the asset I raised the concern about — is the most robust of the three.** 43 of its top 50 are picked by all three drafts, the union across drafts is only 56, and the averaged key keeps 46 of the 50 the mixed draft alone gave. Its neighbours are gene and cell therapies whichever draft you use; the text components shuffle the ranking *within* the set, not the set itself. So the old single-draft figures were substantially right, and the method change is principle rather than correction.

**ASC-204 is the least stable — 23 of 50, union 83 — and I never flagged it.** It doesn't matter, because its comparable set comes from cluster + therapeutic area and never touches retrieval.

**My specific worry didn't materialise either.** I said ASC-101 might cross the 30% screen and switch from a 1,050-row base rate to a 50-neighbour set. It sat at 22% under the old key and sits at 22% under the new one. No readout changed its basis.

**Total consequence: three of ASC-370's fifty neighbours swapped.** Comparable p90 +8.0% → +10.1%, p10 −22.8% → −23.0%, n 43 → 42. Every model point estimate and band is byte-identical.

The label fixes all landed: cell 113's price-series wording, and cell 122 now prints `outcome separation 27 pp (31%) + band contribution 61 pp (69%)` — an identity that actually holds — plus the disclosure/price split and the corrected fold-draw label.

So: worth doing, and the honest write-up is that the test cleared the concern rather than confirming it. That's a stronger thing to have in Q4a(v) than the limitation paragraph was — it's a checked claim instead of a hedge.

Remaining for submission: Member ID and Date (cell 0), the YouTube URL (cell 133), and the AI-use sections for Q1, Q2, Q3 and Q5.

## You  _00:45_

okay lets export this chat to ai_logs

## Claude  _00:46_

<details><summary>tools run</summary>

- `Bash: Inspect the export script and log conventions`

</details>

<details><summary>tools run</summary>

- `Bash: Look for a local session transcript file`

</details>

<details><summary>tools run</summary>

- `Bash: Check the project session directory`

</details>

The session transcript is here. Let me check the script's interface and run it.

<details><summary>tools run</summary>

- `Bash: Read the rest of the export script`

</details>

<details><summary>tools run</summary>

- `Bash: Read the script's CLI and output naming`

</details>

<details><summary>tools run</summary>

- `Bash: Run the export script`

</details>
